TME Pharma NV (ALTME)

Paris
Currency in EUR
0.0745
-0.0008(-1.06%)
Closed
ALTME Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.07350.0755
52 wk Range
0.06110.4360
Key Statistics
Edit
Prev. Close
0.0753
Open
0.0754
Day's Range
0.0735-0.0755
52 wk Range
0.0611-0.436
Volume
106.53K
Average Volume (3m)
557.33K
1-Year Change
-67.75%
Book Value / Share
0.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALTME Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
0.6100
Upside
+718.79%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

TME Pharma NV Company Profile

TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. The company is also developing NOX-E36, which has completed Phase 1/2 clinical trial for the treatment of diabetic nephropathy. The company was formerly known as NOXXON Pharma N.V. and changed its name to TME Pharma N.V. in July 2022. TME Pharma N.V. was founded in 1997 and is headquartered in Berlin, Germany.

Compare ALTME to Peers and Sector

Metrics to compare
ALTME
Peers
Sector
Relationship
P/E Ratio
−1.1x−2.6x−0.6x
PEG Ratio
−0.01−0.010.00
Price/Book
4.5x1.8x2.6x
Price / LTM Sales
-5.1x3.1x
Upside (Analyst Target)
-202.8%52.8%
Fair Value Upside
Unlock7.8%8.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.6100
(+718.79% Upside)

Earnings

Latest Release
Apr 18, 2023
EPS / Forecast
-12.86 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.0126
ALTD
+1.61%
0.24
POXEL
-11.28%
15.06
MEDCL
-0.79%
20.06
ALTAI
-8.40%
5.38
ADOC
+0.37%

FAQ

What Is the TME Pharma NV (ALTME) Stock Price Today?

The TME Pharma NV stock price today is 0.0745

What Stock Exchange Does TME Pharma NV Trade On?

TME Pharma NV is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for TME Pharma NV?

The stock symbol for TME Pharma NV is "ALTME."

What Is the TME Pharma NV Market Cap?

As of today, TME Pharma NV market cap is 7.01M.

What is TME Pharma NV Earnings Per Share?

The TME Pharma NV EPS is -0.372.

From a Technical Analysis Perspective, Is ALTME a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.